Yazar "Johnston, E.L." için listeleme
-
nextMONARCH 1: Phase 2 study of abemaciclib plus tamoxifen or abemaciclib alone in HR+, HER2-advanced breast cancer
Hamiton, E.; Cortes, J.; Dieras, V.; Ozyilkan, O.; Chen, S-C.; Petrakova, K.; Manikhas, A.; Jerusalem, G.; Hegg, R.; Lu, Y.; Bear, M.M.; Johnston, E.L.; Martin, M. (2019) -
nextMONARCH: Final overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with HR+, HER2-metastatic breast cancer
Hamilton, E.P.; Cortes, J.; Ozyilkan, O.; Chen, S-C.; Petrakova, K.; Manikhas, A.; Jerusalem, G.; Hegg, R.; Huober, J.; Chapman, S.C.; Yang, Z.; Chen, Y.; Johnston, E.L.; Martin, M. (2020)